Insight into illness, neurocognition and quality of life in schizophrenia

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 2, 2012, Pages 271-276

  Boyer, L ^a,b   Aghababian, V ^c   Richieri, R ^d   Loundou, A ^e   Padovani, R ^d   Simeoni, M C ^a   Auquier, P ^a   Lancon C ^a,d  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c University of Provence Aix Marseille University   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Insight into illness; Neurocognition; Quality of life; Schizophrenia

Indexed keywords

ADULT; ARTICLE; ATTENTION; COGNITION; CROSS-SECTIONAL STUDY; EMPLOYMENT STATUS; EXECUTIVE FUNCTION; FEMALE; FRANCE; HUMAN; INTROSPECTION; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEMORY; NEGATIVE SYNDROME; NEUROPSYCHOLOGICAL TEST; POSITIVE SYNDROME; QUALITY OF LIFE; SCHIZOPHRENIA; SELF REPORT; TEACHING HOSPITAL;

ADULT; ATTITUDE TO HEALTH; AWARENESS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SELF REPORT;

EID: 84855351722     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.10.008     Document Type: Article

References (60)

1. Addington J., Addington D. Social and cognitive functioning in psychosis. Schizophr Res 2008, 99:176-181.
2. Addington J., Saeedi H., Addington D. The course of cognitive functioning in first episode psychosis: changes over time and impact on outcome. Schizophr Res 2005, 78:35-43.
3. Aghababian V., Auquier P., Baumstarck-Barrau K., Lançon C. Relationship between insight and self-reported quality of life among shizophrenic patients. Encéphale 2011, 37:162-171.
4. Aksaray G., Oflu S., Kaptanoglu C., Bal C. Neurocognitive deficits and quality of life in outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2002, 26:1217-1219.
5. Amador X.F., Flaum M., Andreasen N.C., Strauss D.H., Yale S.A., Clark S.C., et al. Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry 1994, 51:826-836.
6. Amador X.F., Strauss D.H. The scale to assess unawareness of mental disorder 1990, Columbia University and New York Psychiatric Institute, New York.
7. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., Gorman J.M. Assessment of insight in psychosis. Am J Psychiatry 1993, 150:873-879.
8. Andreasen N.C., Calarge C.A., O'Leary D.S. Theory of mind and schizophrenia: a positron emission tomography study of medication-free patients. Schizophr Bull 2008, 34:708-719.
9. Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, DC. 4rd ed.
10. Appelberg B., Tuisku K., Joffe G. Is it worth while changing clinically stable schizophrenic out-patients with mild to moderate residual symptoms and/or side effects from conventional to atypical antipsychotics? A prospective, randomised study with olanzapine. Eur Psychiatry 2004, 19:516-518.
11. Bechdolf A., Klosterkotter J., Hambrecht M., Knost B., Kuntermann C., Schiller S., et al. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2003, 253:228-235.
12. Bora E., Sehitoglu G., Aslier M., Atabay I., Veznedaroglu B. Theory of mind and unawareness of illness in schizophrenia: is poor insight a mentalizing deficit?. Eur Arch Psychiatry Clin Neurosci 2007, 257:104-111.
13. Boyer L., Simeoni M.C., Loundou A., D'Amato T., Reine G., Lancon C., et al. The development of the S-QoL 18: a shortened quality of life questionnaire for patients with schizophrenia. Schizophr Res 2010, 121:241-250.
14. Brekke J., Kay D.D., Lee K.S., Green M.F. Biosocial pathways to functional outcome in schizophrenia. Schizophr Res 2005, 80:213-225.
15. Brickenkamp R. D2 - test d'attention concentrée 2007, Hogrefe.
16. Brissos S., Dias V.V., Carita A.I., Martinez-Aran A. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates. Psychiatry Res 2008, 160:55-62.
17. Caron J., Mercier C., Diaz P., Martin A. Socio-demographic and clinical predictors of quality of life in patients with schizophrenia or schizo-affective disorder. Psychiatry Res 2005, 137:203-213.
18. CNIL = Act n°78-17 of 6 January 1978 on Data Processing, Data Files and Individual Liberties (amended by the Act of 6 August 2004 relating to the protection of individuals with regard to the processing of personal data). Journal officiel de la République Française. Assemblée Nationale et Sénat. France.
19. Cohen C.I., Hassamal S.K., Begum N. General coping strategies and their impact on quality of life in older adults with schizophrenia. Schizophr Res 2011, 127:223-228.
20. Cramer J.A., Rosenheck R., Xu W., Thomas J., Henderson W., Charney D.S. Quality of life in schizophrenia: a comparison of instruments. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Schizophr Bull 2000, 26:659-666.
21. Eack S.M., Newhill C.E. Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis. Schizophr Bull 2007, 33:1225-1237.
22. Fitzgerald P.B., Williams C.L., Corteling N., Filia S.L., Brewer K., Adams A., et al. Subject and observer-rated quality of life in schizophrenia. Acta Psychiatr Scand 2001, 103:387-392.
23. Folsom D.P., Depp C., Palmer B.W., Mausbach B.T., Golshan S., Fellows I., et al. Physical and mental health-related quality of life among older people with schizophrenia. Schizophr Res 2009, 108:207-213.
24. Galletly C.A., Clark C.R., McFarlane A.C., Weber D.L. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine. Psychiatry Res 1997, 72:161-166.
25. Hasson-Ohayon I., Kravetz S., Roe D., David A.S., Weiser M. Insight into psychosis and quality of life. Compr Psychiatry 2006, 47:265-269.
26. Heslegrave R.J., Awad A.G., Voruganti L.N. The influence of neurocognitive deficits and symptoms on quality of life in schizophrenia. J Psychiatry Neurosci 1997, 22:235-243.
27. Hofer A., Baumgartner S., Bodner T., Edlinger M., Hummer M., Kemmler G., et al. Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry 2005, 20:395-402.
28. Hofer A., Baumgartner S., Edlinger M., Hummer M., Kemmler G., Rettenbacher M.A., et al. Patient outcomes in schizophrenia I: correlates with sociodemographic variables, psychopathology, and side effects. Eur Psychiatry 2005, 20:386-394.
29. Jahn T., Pitschel-Walz G., Gsottschneider A., Frobose T., Kraemer S., Bauml J. Neurocognitive prediction of illness knowledge after psychoeducation in schizophrenia: results from the Munich COGPIP study. Psychol Med 2011, 41:533-544.
30. Kurtz M.M., Tolman A. Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?. Schizophr Res 2011 Apr, 127(1-3):157-162.
31. Kurtz M.M., Wexler B.E., Fujimoto M., Shagan D.S., Seltzer J.C. Symptoms versus neurocognition as predictors of change in life skills in schizophrenia after outpatient rehabilitation. Schizophr Res 2008, 102:303-311.
32. Lysaker P.H., Buck K.D., Salvatore G., Popolo R., Dimaggio G. Lack of awareness of illness in schizophrenia: conceptualizations, correlates and treatment approaches. Expert Rev Neurother 2009, 9:1035-1043.
33. Lysaker P.H., Roe D., Yanos P.T. Toward understanding the insight paradox: internalized stigma moderates the association between insight and social functioning, hope, and self-esteem among people with schizophrenia spectrum disorders. Schizophr Bull 2007, 33:192-199.
34. Lysaker P.H., Shea A.M., Buck K.D., Dimaggio G., Nicolo G., Procacci M., et al. Metacognition as a mediator of the effects of impairments in neurocognition on social function in schizophrenia spectrum disorders. Acta Psychiatr Scand 2011, 122:405-413.
35. Matsui M., Sumiyoshi T., Arai H., Higuchi Y., Kurachi M. Cognitive functioning related to quality of life in schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:280-287.
36. Moritz S., Veckenstedt R., Randjbar S., Vitzthum F., Woodward T.S. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. Psychol Med 2011, 1-10.
37. Murphy E.R., Brent B.K., Benton M., Pruitt P., Diwadkar V., Rajarethinam R.P., et al. Differential processing of metacognitive evaluation and the neural circuitry of the self and others in schizophrenia: a pilot study. Schizophr Res 2011, 116:252-258.
38. Narvaez J.M., Twamley E.W., McKibbin C.L., Heaton R.K., Patterson T.L. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008, 98:201-208.
39. Prouteau A., Verdoux H., Briand C., Lesage A., Lalonde P., Nicole L., et al. Cognitive predictors of psychosocial functioning outcome in schizophrenia: a follow-up study of subjects participating in a rehabilitation program. Schizophr Res 2005, 77:343-353.
40. Quee P.J., van der Meer L., Bruggeman R., de Haan L., Krabbendam L., Cahn W., et al. Insight in psychosis: relationship with neurocognition, social cognition and clinical symptoms depends on phase of illness. Schizophr Bull 2011, 37:29-37.
41. Quercioli C., Messina G., Barbini E., Carriero G., Fani M., Nante N. Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores. Eur J Health Econ 2009 Oct, 10(4):389-397.
42. Reitan R.M. Trail making test: manual for administration and scoring 1992, Reitan Neuropsychology Laboratory.
43. Roe D., Hasson-Ohayon I., Derhi O., Yanos P.T., Lysaker P.H. Talking about life and finding solutions to different hardships: a qualitative study on the impact of narrative enhancement and cognitive therapy on persons with serious mental illness. J Nerv Ment Dis 2010, 198:807-812.
44. Sibitz I., Amering M., Unger A., Seyringer M.E., Bachmann A., Schrank B., et al. The impact of the social network, stigma and empowerment on the quality of life in patients with schizophrenia. Eur Psychiatry 2011, 26:28-33.
45. Sibitz I., Unger A., Woppmann A., Zidek T., Amering M. Stigma resistance in patients with schizophrenia. Schizophr Bull 2011, 37:316-323.
46. Staring A.B., Van der Gaag M., Van den Berge M., Duivenvoorden H.J., Mulder C.L. Stigma moderates the associations of insight with depressed mood, low self-esteem, and low quality of life in patients with schizophrenia spectrum disorders. Schizophr Res 2009, 115:363-369.
47. Szoke A., Trandafir A., Dupont M.E., Meary A., Schurhoff F., Leboyer M. Longitudinal studies of cognition in schizophrenia: meta-analysis. Br J Psychiatry 2008, 192:248-257.
48. Test M.A., Greenberg J.S., Long J.D., Brekke J.S., Burke S.S. Construct validity of a measure of subjective satisfaction with life of adults with serious mental illness. Psychiatr Serv 2005, 56:292-300.
49. Tharyan A., Saravanan B. Insight and psychopathology in schizophrenia. Indian J Psychiatry 2000, 42:421-426.
50. Thornicroft G., Tansella M., Becker T., Knapp M., Leese M., Schene A., et al. The personal impact of schizophrenia in Europe. Schizophr Res 2004, 69:125-132.
51. Tolman A.W., Kurtz M.M. Neurocognitive predictors of objective and subjective quality of life in individuals with schizophrenia: a meta-analytic investigation. Schizophr Bull 2010 Jull 11, [Epub ahead of print]. doi:10.1093/schbul/sbq077.
52. van Zelst C. Stigma and schizophrenia. Lancet 2009, 373:1336. author reply 1336-1337.
53. van Zelst C. Stigmatization as an environmental risk in schizophrenia: a user perspective. Schizophr Bull 2009, 35:293-296.
54. Verdoux H., Goumilloux R., Monello F., Cougnard A. Occupational outcome of patients with schizophrenia after first request for disability status: a 2-year follow-up study. Encéphale 2011, 36:484-490.
55. Wechsler D. Weschler Memory Scale 1997, The Psychological Corporation. 3rd ed.
56. WMA = Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects. World Medical Association, General Assembly, Seoul, October 2008.
57. Woon P.S., Chia M.Y., Chan W.Y., Sim K. Neurocognitive, clinical and functional correlates of subjective quality of life in Asian outpatients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011, 34:463-468.
58. Wykes T., Huddy V., Cellard C., McGurk S.R., Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry 2011, 168:472-485.
59. Yanos P.T., Lysaker P.H., Roe D. Internalized stigma as a barrier to improvement in vocational functioning among people with schizophrenia-spectrum disorders. Psychiatry Res 2010, 178:211-213.
60. Young D.A., Campbell Z., Zakzanis K.K., Weinstein E. A comparison between an interview and a self-report method of insight assessment in chronic schizophrenia. Schizophr Res 2003, 63:103-109.